Formycon Partners With Leukocare For Stable Biosimilar Formulations
Formycon Has Three Biosimilars In Advanced Development
Leukocare will apply its formulation and bioinformatics expertise to Formycon’s “comprehensive development knowhow.” • Source: Shutterstock 
